Skip to main content

New ChEMBL ligand-based target predictions docker image available


Resultado de imagen de zoltar fortune


One year ago we published a new version of our target prediction models and since then we've been working on its implementation for the upcoming ChEMBL 26 release.

What did we do?

First of all we re-trained the models with the LightGBM library instead of using scikit-learn. By doing this and tuning a bit the parameters our prediction timing improved by 2 orders of magnitude while keeping comparable prediction power. Having quicker models allowed us to easily implement a simple web service providing real time predictions.

Since we are currently migration to a more sustainable Kubernetes infrastructure it made sense to us to directly write the small target prediction web service as a cloud native app. We then decided to give OpenFaaS a try as a platform to deploy machine learning models.

OpenFaaS is a framework for building serverless functions with Docker and Kubernetes. It provides templates for deploying functions as REST endpoints in many different programming languages (Python, Node, Java, Ruby, go...).

Our target predicitons OpenFaaS function source code is now available in our github repository. A Docker image with ready to use ChEMBL 25 trained models is also available here.

Does this mean that you won't be able to use the models without an Kubernetes/OpenFaaS installation? No way! It is also easy to start an instance in your local machine:

docker run -p 8080:8080 chembl/mcp:25
# in a different shell
curl -X POST -H 'Accept: */*' -H 'Content-Type: application/json' -d '{"smiles": "CC(=O)Oc1ccccc1C(=O)O"}' http://127.0.0.1:8080

Bear in mind that the service needs to load the models into memory, so it may take few minutes until it returns predictions. The predictions returned by the service are the ones for the models with CCR ((sensitivity + specificity) / 2) >= 0.85

Comments

Chris said…
Hi, Tried to use Docker

docker run -p 8080:8080 chembl/mcp
Forking - python [index.py]
2020/02/06 10:54:02 Started logging stderr from function.
2020/02/06 10:54:02 Started logging stdout from function.
2020/02/06 10:54:02 OperationalMode: http
2020/02/06 10:54:02 Timeouts: read: 10s, write: 10s hard: 10s.
2020/02/06 10:54:02 Listening on port: 8080
2020/02/06 10:54:02 Writing lock-file to: /tmp/.lock
2020/02/06 10:54:02 Metrics listening on port: 8081
2020/02/06 10:54:31 Upstream HTTP request error: Post http://127.0.0.1:5000/: dial tcp 127.0.0.1:5000: connect: connection refused
2020/02/06 10:54:46 Forked function has terminated: signal: killed

when I try this in another Terminal window

curl -X POST -H 'Accept: */*' -H 'Content-Type: application/json' -d '{"smiles": "CC(=O)Oc1ccccc1C(=O)O"}' http://127.0.0.1:8080
Eloy said…
Hi Chris,

Are you using Docker on Windows or Mac?
It's default config (Docker on Windows and Mac actually runs inside a tiny VM) allows it only to use 2GB of RAM and it looks like it's killing the container process because Docker runs out of memory when loading the models.
You'll need to change Docker config to allow it to use 8GB of system memory.

Kind regards,
Eloy

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

Mapping lists of IDs in ChEMBL

In order to facilitate the mapping of identifiers in ChEMBL, we have developed a new type of search in the ChEMBL Interface. Now, it is possible to enter a list of ChEMBL IDs and see a list of the corresponding entities. Here is an example: 1. Open the ChEMBL Interface , on the main search bar, click on 'Advanced Search': 2. Click on the 'Search by IDs' tab: 3. Select the source entity of the IDs and the destination entity that you want to map to: 4. Enter the identifiers, you can either paste them, or select a file to upload. When you paste IDs, by default it tries to detect the separator. You can also select from a list of separators to force a specific one: Alternatively, you can upload a file, the file can be compressed in GZIP and ZIP formats, this makes the transfer of the file to the ChEMBL servers faster. Examples of the files that can be uploaded to the search by IDs can be found  here . 5. Click on the search button: 6. You will be redirected to a search resul